Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting tomorrow, June 13th.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Steris
Symbol: STE
Recent Price: $220.89
Average Analyst Price Target: $256.00 (15.89%)
Market Cap: $22.11B
Expected Ex-Dividend Date: Jun 13 2022
Expected Payment Date: Jun 28 2022
Expected Dividend & Yield: 0.75%
Recent Analyst Action: David Turkaly, analyst at JMP Securities, reiterates coverage on Steris (STE) in the Healthcare sector with a Buy rating and a price target of $ 270 (2 weeks ago).
TipRanks.com also reports that Steris currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $256.00 . The target pricing ranges from a high forecast of $270.00 down to a low forecast of $248.00. Steris (STE)’s last closing price was $$220.89 which would put the average price target at 15.89% upside.Here are 3rd party ratings for STE:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Bottom 29% (174 out of 251)
--------------------------------------------------------------------------
Stevanato Group
Symbol: STVN
Recent Price: $14.84
Average Analyst Price Target: $20.50 (38.14%)
Market Cap: $3.93B
Expected Ex-Dividend Date: Jun 13 2022
Expected Payment Date: Jul 13 2022
Expected Dividend & Yield:
Recent Analyst Action: David Windley, analyst at Jefferies, reiterates coverage on Stevanato Group (STVN) in the Healthcare sector with a Buy rating and a price target of $ 18 (3 days ago).
TipRanks.com also reports that Stevanato Group currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $20.50 . The target pricing ranges from a high forecast of $26.00 down to a low forecast of $18.00. Stevanato Group (STVN)’s last closing price was $$14.84 which would put the average price target at 38.14% upside.Here are 3rd party ratings for STVN:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 41% (104 out of 251)
--------------------------------------------------------------------------
HCA Healthcare
Symbol: HCA
Recent Price: $196.72
Average Analyst Price Target: $254.06 (29.15%)
Market Cap: $58.13B
Expected Ex-Dividend Date: Jun 15 2022
Expected Payment Date: Jun 30 2022
Expected Dividend & Yield: 1.01%
Recent Analyst Action: Lance Wilkes, analyst at Bernstein, reiterates coverage on HCA Healthcare (HCA) in the Healthcare sector with a Buy rating and a price target of $ 271 (2 weeks ago).
TipRanks.com also reports that HCA Healthcare currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $254.06 . The target pricing ranges from a high forecast of $275.00 down to a low forecast of $227.00. HCA Healthcare (HCA)’s last closing price was $$196.72 which would put the average price target at 29.15% upside.Here are 3rd party ratings for HCA:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Bottom 28% (180 out of 251)
--------------------------------------------------------------------------
UnitedHealth
Symbol: UNH
Recent Price: $484.63
Average Analyst Price Target: $588.00 (21.33%)
Market Cap: $454.67B
Expected Ex-Dividend Date: Jun 16 2022
Expected Payment Date: Jun 28 2022
Expected Dividend & Yield: 1.22%
Recent Analyst Action: Lance Wilkes, analyst at Bernstein, reiterates coverage on UnitedHealth (UNH) in the Healthcare sector with a Hold rating and a price target of $ 561 (2 weeks ago).
TipRanks.com also reports that UnitedHealth currently has 19 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $588.00 . The target pricing ranges from a high forecast of $665.00 down to a low forecast of $485.00. UnitedHealth (UNH)’s last closing price was $$484.63 which would put the average price target at 21.33% upside.Here are 3rd party ratings for UNH:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 41% (104 out of 251)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
